GL1X · GenesisL1 explorer

Research workbench

Fragment-based approach to the design of ligands targeting a novel site on HIV-1 integrase

Analyse Fragment-based approach to the design of ligands targeting a novel site on… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3AO3
Type
protein
Length
272 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Pol polyprotein
UniProt
Q72498
Ligands
BMC, CD, SO4, CL
Pockets
5 · best druggability 0.52

Structure

x-ray diffraction · 2 distinct chains · 50% helix, 21% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
APol polyproteinprotein13850% helix, 21% strandQ72498
BPol polyproteinprotein13450% helix, 21% strandQ72498

Ligands and binding sites

  • BMC · 3-(1,3-benzodioxol-5-yl)-1-methyl-1H-pyrazole-5-carboxylic acid · ligand · 2 copies · chains A, B
  • CD · Cadmium ion · metal · 4 copies · chains A, B
  • SO4 · Sulfate ion · ion · 6 copies · chains A, B
  • CL · Chloride ion · ion · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11360.520.8018empty
21150.490.8024BMC
31090.490.8021BMC
41060.470.7916empty
51130.460.7816empty

Interfaces

1 interface between chains.

  • A–B · 1526 Ų buried · 18 hydrogen bonds · protein-protein

Compared structures

  • 3AO3 · Fragment-based approach to the design of ligands targeting a novel site on HIV-1 integrase · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.